Al-Saif Stores for Development & Investment Company (TADAWUL:4192)

Verve Therapeutics Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.68	68.42	24.15	46.89	46.7	66.17
Trading Asset Securities	-	-	-	-	-	14.91
Cash & Short-Term Investments	13.68	68.42	24.15	46.89	46.7	81.08
Cash Growth	18.38%	183.34%	-48.50%	0.40%	-42.40%	-47.87%
Accounts Receivable	5.42	6.65	12.36	5.93	5.31	3.68
Other Receivables	0.01	1.23	1.33	37.46	7.05	0.93
Receivables	5.43	7.87	13.68	43.39	12.36	4.61
Inventory	365.34	282.75	409.61	239.07	258.25	188.99
Prepaid Expenses	47.91	25.53	23.54	21.41	25.35	19.99
Other Current Assets	-	8.31	29.79	10.78	4.69	24.23
Total Current Assets	432.36	392.88	500.77	361.54	347.35	318.9
Property, Plant & Equipment	361.88	346.95	438.73	289.43	263.65	222.93
Other Intangible Assets	1	1.2	1.48	1.61	-	-
Total Assets	795.24	741.03	940.98	652.58	611	541.83
Accounts Payable	39.51	27.54	40.41	44.56	21.24	16.04
Accrued Expenses	21.88	10.62	17.82	15.33	18.28	18.54
Short-Term Debt	37.33	65.35	230.66	0.05	52.63	-
Current Portion of Long-Term Debt	-	-	-	-	-	48.14
Current Portion of Leases	31.07	27.09	26.16	18.23	14.78	12.23
Current Income Taxes Payable	11.28	7.28	4.55	7.75	6.01	5.17
Current Unearned Revenue	-	-	-	-	1.51	1.72
Other Current Liabilities	0.02	5.17	9.56	35	0.81	1.56
Total Current Liabilities	141.1	143.05	329.16	120.91	115.25	103.39
Long-Term Leases	166.76	147.65	198.8	112.17	107.11	85.59
Total Liabilities	319.41	301.82	538.43	241.47	229.87	193.99
Common Stock	350	350	350	350	42	42
Additional Paid-In Capital	0.16	0.16	0.16	0.16	0.16	0.16
Retained Earnings	125.67	89.05	52.4	60.95	338.98	305.68
Shareholders' Equity	475.83	439.21	402.55	411.11	381.14	347.84
Total Liabilities & Equity	795.24	741.03	940.98	652.58	611	541.83
Total Debt	235.16	240.09	455.61	130.45	174.51	145.96
Net Cash (Debt)	-221.48	-171.67	-431.46	-83.56	-127.8	-64.89
Net Cash Per Share	-0.63	-0.49	-1.23	-0.24	-3.04	-1.54
Filing Date Shares Outstanding	350	350	350	350	42	42
Total Common Shares Outstanding	350	350	350	350	42	42
Working Capital	291.26	249.83	171.61	240.63	232.11	215.51
Book Value Per Share	1.36	1.25	1.15	1.17	9.07	8.28
Tangible Book Value	474.83	438.01	401.07	409.5	381.14	347.84
Tangible Book Value Per Share	1.36	1.25	1.15	1.17	9.07	8.28
Land	-	36.59	70.06	55.53	-	23.55
Buildings	-	45.31	28.41	25.47	-	27.85
Machinery	-	28.12	24.38	21.36	-	16.61
Construction In Progress	-	0.14	25.46	0.92	-	5.83
Leasehold Improvements	-	44.53	40.73	32.65	-	24.97

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.